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His230 of serine hydroxymethyltransferase facilitates the proton
abstraction step in catalysis
Rashmi Talwar, Junutula R. Jagath, N. Appaji Rao and H. S. Savithri
Department of Biochemistry, Indian Institute of Science, Bangalore, India
The three-dimensional structures of rabbit and human liver cytosolic serine hydroxymethyltransferase revealed
that H231 interacts with the O3 0 of pyridoxal-5 0-phosphate and other residues at the active site such as S203,
K257, H357 and R402 (numbering as per the human enzyme). This and the conserved nature of H231 in all serine
hydroxymethyltransferases highlights its importance in catalysis and/or maintenance of oligomeric structure of
the enzyme. In an attempt to decipher the role of H230 (H231 of the human enzyme) in the catalytic mechanism
and/or maintenance of oligomeric structure of sheep liver serine hydroxymethyltransferase, the residue was
mutated to arginine, phenylalanine, alanine, asparagine or tyrosine. Our results suggest that the nature of the
amino acid substitution has a marked effect on the catalytic activity of the enzyme. H230R and H230F mutant
proteins were completely inactive, dimeric and did not bind pyridoxal-5 0-phosphate. On the other hand, mutation
to alanine and asparagine retained the oligomeric structure and ability to bind pyridoxal-5 0-phosphate. These
mutants had only 2±3% catalytic activity. The side reactions like transamination and 5,6,7,8-tetrahydrofolate
independent aldol cleavage were much more severely affected. They were able to form the external aldimine with
glycine and serine but the quinonoid intermediate was not observed upon the addition of 5,6,7,8-tetrahydrofolate.
Mutation to tyrosine did not affect the oligomeric structure and pyridoxal-5 0-phosphate binding. The H230Y
enzyme was 10% active and showed a correspondingly lower amount of quinonoid intermediate. The kcat / Km
values for l-serine and l-allothreonine were 10-fold and 174-fold less for this mutant enzyme compared to the
wild-type protein. These results suggest that H230 is involved in the step prior to the formation of the quinonoid
intermediate, possibly in orienting the pyridine ring of the cofactor, in order to facilitate effective proton
abstraction.
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Serine hydroxymethyltransferase (SHMT, E.C.2.1.2.1), a pyri-
doxal-5 0-phosphate dependent enzyme, catalyzes the conversion
of serine and 5,6,7,8-tetrahydrofolate (H4-folate) to glycine and
5,10-methylene-H4-folate (5,10-CH2-H4-folate) [1]. Like other
PLP-dependent enzymes, SHMT exhibits broad substrate and
reaction specificity, as it also catalyzes H4-folate-independent
aldolytic cleavage, decarboxylation, racemization and trans-
amination reactions. The X-ray structure of the human liver
cytosolic SHMT (hcSHMT) [2] revealed that the tetrameric
protein was a `dimer of dimers', stabilized by the N-terminal
arm as suggested earlier by mutational studies on sheep liver
cytosolic SHMT (scSHMT) [3]. PLP is bound to K257 as a
Schiff's base linkage and is present at the interface of the tight
dimers. The protonated N1 nitrogen of PLP is hydrogen bonded
to D228, which, in turn, is bonded to H151. H231 is involved in
hydrogen bonding interactions with the O3 0 of PLP. In addition,
it is within hydrogen-bonding distance of S203, K257, H357
and R402. The phosphate group of PLP is hydrogen bonded to
various residues including Y73 and G303 from the neighboring
subunit. More recently, Scarsdale et al. [4] reported the three-
dimensional structure of rabbit liver cytosolic SHMT (rcSHMT),
which confirms these features in the structure of SHMT. They
have also examined in detail the implications of the structure to
the catalytic mechanism of the reaction.
Histidine, at position 230 of scSHMT (H231 of hcSHMT), is
completely conserved in the primary structure of all SHMTs
known so far [5]. The three-dimensional structure of aspartate
aminotransferase (AATase) showed that a tyrosine was present
at the equivalent position and was hydrogen bonded to the O3 0
of PLP [6]. However, Y225 was conserved only in < 70% of
the AATase sequences known so far. H207 of 8-amino-7-
oxononanoate synthase [7], A186 of serine-pyruvate
aminotransferase, T319 of ornithine decarboxylase and Q246
of dialkylglycine decarboxylase [9] occupy positions equivalent
to Y225 of AATase. The role of this residue in catalysis has not
been examined in any of the above mentioned enzymes, except
for AATase, in which a Y225R mutation led to a complete loss
of transaminase activity [10]. It was therefore of interest to
mutate H230 to arginine in analogy with the studies on AATase;
to alanine, a conservative choice in mutational studies; to
tyrosine, which mimics the situation in AATase; to phenyl-
alanine, in order to decipher the role of the hydroxyl group; or
to asparagine, which is a conservative mutation with steric
effects similar to those of histidine but has a neutralized charge.
The results obtained in this study clearly demonstrate that
mutation of H230 leads to a dramatic reduction in the catalytic
activity of SHMT and also changes in its oligomeric structure
depending on the nature of the substitution.
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E X P E R I M E N T A L P R O C E D U R E S
Glycine, l-serine, d-alanine, NADH, b-phenylserine, 2-mercapto-
ethanol, folic acid, PLP, EDTA, aminooxyacetic acid, methoxy-
amine (MA), l-aspartate, a-ketoglutarate and l-allothreonine
were obtained from Sigma Chemicals Co. St. Louis, MO,
USA. [a-32P]dATP (3000 Ci´mmol21) and l-[3-14C]serine
(55 mCi´mmol21), restriction endonucleases (KpnI, BamHI and
Pml I), Sequenase Version 2 DNA sequencing kit and DNA
modifying enzymes (T4 DNA ligase, Klenow fragment) were
obtained from Amersham Pharmacia Biotech, Bucks, UK.
[2-3H]Glycine (41.1 Ci´mmol21) was purchased from NEN
Life Science Products, Inc. Boston, MA, USA. Pfu polymerase
was purchased from Stratagene and Deep Vent polymerase
from New England Biolabs, Inc., Beverly, MA, USA. Sephacryl
S-200, Superose 12 HR 10/30 were purchased from Pharmacia,
Uppsala, Sweden. The oligonucleotide primers were custom
synthesized by Bangalore Genei Pvt. Ltd, India. H4-Folate
was prepared by the method of Hatefi et al. [11]. All other
biochemicals used in this study were of the highest purity
available.
Bacterial strains and growth conditions
Escherichia coli DH5a was the recipient strain for the plasmids
used in subcloning and sequencing. Strain BL21(DE3) pLysS
[12] was used for bacterial expression of pET and pRSET
constructs. CJ236 was the strain of choice for preparation of
single strand DNA. Luria±Bertani medium or terrific broth
with 50 mg´mL21 of ampicillin was used for growing E. coli
cells.
DNA manipulations
Plasmids were prepared by the alkaline lysis method as
described by Sambrook et al. [13]. Restriction analysis and
DNA ligations were carried out according to the manufacturer's
instructions. Competent cells were prepared by the procedure of
Alexander [14].
Site-directed mutagenesis
All the H230 mutants except H230R were constructed by the
PCR based megaprimer method [15,16]. The oligonucleotides
used for the generation of mutants are as follows: H230A,
5 0-GAC ATG GCA GCG ATA TCC GGG CTG GTG GC-3 0;
H230F, 5 0-C ATG GCA TTT ATC AGC GG-3 0; H230N, 5 0-AC
ATG GCA AAT ATT AGC GGG CTG-3 0; H230R, 5 0-G GCT
GAC ATG GCG CGC ATC AGC GGG C-3 0; H230Y, 5 0-AC
ATG GCA TAT ATC AGC G-3 0; M13 universal reverse primer
(19-mer), 5 0-GGA AAC AGC TAT GAC CAT G-3 0; and SHP1
(19-mer), 5 0-T ATG GCA GCT CCA GTC AAC-3 0.
The full length PCR product was subcloned into pUC19 at
KpnI and BamHI sites. The clone was double digested with
KpnI and PmlI to obtain the 0.5 kb fragment that was swapped
with the corresponding 0.5 kb fragment of the wild-type clone,
i.e. pETSH (SHMT gene in pET 3c). The entire 0.5 kb region
was sequenced using Sequenase Version 2 DNA sequencing kit
to confirm the presence of the desired mutation and the absence
of any nonspecific mutation(s). The H230R mutation was
generated by the conventional Kunkel's method [17] using
pGSH [SHMT gene subcloned in pGEM 3z f(±) vector] as a
template. The product was similarly subcloned to obtain the
mutant in the expression vector.
Expression and purification of H230 mutant proteins
The scSHMT and the mutant enzymes were purified by the
protocol described earlier [3]. Briefly, the BL21(DE3) pLysS
extracts were subjected to ammonium sulphate fractionation,
CM-Sephadex and Sephacryl S-200 column chromatography.
The fractions were pooled and precipitated with 65% ammonium
sulphate and the pellet was resuspended in Buffer A (50 mm
phosphate buffer, pH 7.4, 1 mm EDTA and 1 mm 2-mercapto-
ethanol). It was dialyzed against the same buffer with two
changes and was used in all further studies. The amount of
protein was estimated by the method of Lowry et al. [18].
Enzyme assays
Aldol cleavage in the presence of H4-folate was monitored
using l-[3-14C]serine by the method of Manohar et al. [19].
Aldolytic cleavage of l-allothreonine was monitored as
described by Jagath et al. [20]. The rates of transamination of
d-alanine were determined as described earlier [21].
Proton exchange studies
The proton exchange studies were carried out using tritiated
glycine as described by Schirch and Jenkins [22].
Spectral measurements
The absorbance spectra of the wild type and mutant enzymes
(5 mm) were recorded in a Shimadzu UV 160 A spectro-
photometer, both in the presence and absence of ligands and at
different time intervals, when necessary. The oligomeric status
of the proteins was determined using a calibrated Superose 12
HR 10/30 column attached to a Pharmacia FPLC system.
Determination of association constants
The substrate induced quenching of fluorescence of enzyme
bound PLP was monitored using a Jasco FP 777 spectro-
fluorimeter using a modified version of the protocol reported
earlier [23].
R E S U LT S A N D D I S C U S S I O N
Biochemical characterization of the H230 mutants of sheep
liver SHMT showed that the nature of the substitution affects
catalysis and oligomeric status to different extents. It is evident
Table 1. Catalytic efficiency and binding constants of the H230 mutants
of scSHMT. Specific activity is defined as the amount of HCHO (mmol)
formed per min at 37 8C and pH 7.4. Binding constants of H230 mutants
for l-serine and glycine were determined by quenching of the fluorescence
of the enzyme bound PLP
Protein
Specific activity
(U´mg21) % Activity
l-Serine
(mm)
Glycine
(mm)
scSHMT 4.8 100 0.98 12.0
H230A 0.11 2 0.85 11.3
H230N 0.12 2 0.94 12.0
H230F 0.005 0.001 ± ±
H230R 0.005 0.001 ± ±
H230Y 0.52 11 0.86 12.2
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from Table 1 that both H230A and H230N showed only 2±3%
activity compared to scSHMT, and H230F and H230R exhibited a
marked decrease (a thousand-fold) in activity. The H230Y
mutant, however, showed < 12% catalytic activity compared
to scSHMT. Staining for activity upon native PAGE using
b-phenylserine and 2,4-dinitrophenylhydrazine gave the charac-
teristic yellow-orange band [24] only with scSHMT and not
with the mutants (data not shown). Although the H230Y mutant
exhibited < 12% catalytic activity with serine as substrate, it
did not give the yellow-orange band with b-phenylserine,
probably because the method of activity staining is not sensitive
enough to pick up small amounts of benzaldehyde formed.
Spectral and catalytic properties of the H230 mutant
enzymes
The far UV-CD spectra of all the mutant enzymes were
essentially similar to scSHMT, indicating that the mutations
may not have caused major alterations in the secondary
structure (data not shown). The intrinsic tryptophan fluores-
cence emission spectra of all the H230 mutants, except H230Y,
were similar to that of scSHMT (Fig. 1, inset). The H230Y
protein showed a red shift in the emission maximum compared
to scSHMT, suggesting that a subtle change in the environment
around the tryptophan residues may have occurred as a conse-
quence of the mutation. The H230A, H230N and H230Y
mutants exhibited characteristic absorbance at 425 nm (Fig. 1,
curve 1), whereas the H230R and H230F mutants showed very
little absorbance at 425 nm when an equal amount of the
protein (5 mm) was used to record the spectra (Fig. 1, curve 2).
Like scSHMT, the H230A, H230N and H230Y mutants con-
tained one mol of PLP bound per subunit. The addition of
glycine to scSHMT resulted in the formation of a geminal
diamine (343 nm), external aldimine (425 nm) and a very small
amount of the quinionoid intermediate (495 nm). The addition
of glycine to H230Y also showed a small amount of geminal
diamine (data not shown). The addition of H4-folate to a
mixture of scSHMT and glycine (Fig. 1, curve 5) and the
H230Y mutant and glycine (Fig. 1, curve 4) gave the charac-
teristic quinonoid intermediate, but the amount of this with the
H230Y mutant was less. However, unlike scSHMT, the H230A
and H230N mutants did not exhibit the characteristic spectral
intermediates upon the addition of glycine (100 mm) followed
by H4-folate (1.8 mm). This observation suggests that a step
prior to the formation of the quinonoid intermediate was
probably affected in these two mutants. To identify this step,
the catalytic mechanism was examined in detail. The formation
of the external aldimine upon addition of the substrate serine/
glycine is an early step in catalysis. The association constants
for binding of serine and glycine to scSHMT and the H230A,
H230N and H230Y mutant proteins were determined by measur-
ing the substrate-induced fluorescence quenching of the enzyme-
bound PLP (Table 1). The KA values for serine (< 1 mm) and
glycine (< 10 mm) for all the mutants were similar to that for
scSHMT and indicated that they were capable of binding the
substrates. The KA values for the H230R and H230F mutant
proteins could not be determined as they did not contain PLP.
The abstraction of the proton from the external aldimine to
generate the quinonoid intermediate is a stereospecific reaction
and is enhanced by H4-folate [22]. Proton exchange studies
carried out with tritiated glycine revealed that whereas the
H230Y mutant showed 15% exchange compared to scSHMT,
the H230A and H230N mutants showed only < 2% exchange
at 60 mm H4-folate (data not shown), which correlates well with
their observed physiological activity. Due to limitations of the
spectral absorbance measurements, the formation of a small
Fig. 1. The visible absorption spectra of
scSHMT and H230 mutants. Visible absorption
spectra of scSHMT and the H230A, H230N and
H230Y mutants (line 1), and the H230F and
H230R mutants (line 2) were recorded in a
Shimadzu UV-160 A spectrophotometer using
5 mm protein in buffer A. The spectra were
recorded upon addition of 100 mm glycine (line
3) to scSHMT and the H230A, H230N and
H230Y mutants followed by addition of 1.8 mm
H4-folate (line 3, H230A and H230N mutants;
line 4, H230Y mutant; line 5, scSHMT). Inset,
intrinsic tryptophan fluorescence of H230
mutants. Protein (0.5 mm) in buffer A was
excited at 280 nm and the emission spectrum
was recorded between 300 and 400 nm on a
Jasco FP 777 spectrofluorimeter at 25 8C.
scSHMT (± ±); H230A, H230F, H230N and
H230R mutants (Ð); H230Y mutant (± ´ ±).
Table 2. Kinetic parameters for the H4-folate dependent and independent aldolytic cleavage catalyzed by H230Y SHMT. The kinetic constants were
evaluated by a double reciprocal plot of the rate of the reaction vs. varying substrate concentrations.
Km (mm) kcat (s
21) kcat/Km (mm
21´s21)
Protein scSHMT H230Y scSHMT H230Y scSHMT H230Y
l-Serine 1.0 0.9 4.23 0.43 4.23 0.48
l-Allothreonine 1.25 3.0 4.15 0.058 3.32 0.019
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amount of quinonoid intermediate with the H230A and H230N
mutants, if any, cannot be ruled out. The R401A mutant
enzyme, which does not catalyze proton exchange [25], was
used as a negative control. The amount of proton exchange and
the concentration of the quinonoid intermediate formed with
the H230Y mutant (Fig. 1) correlates well with the observed
activity of the mutant, emphasizing that the affected step of
catalysis, namely proton abstraction, is partially restored. These
observations would suggest that the proton transfer step of
catalysis is affected but not fully abolished as a consequence
of the H230A, H230N or H230Y mutations.
The effect of mutation on the alternative reactions such as
H4-folate-independent aldolytic cleavage of l-allothreonine is
shown in Table 2. The Km values for l-allothreonine remained
unaltered but the kcat values were reduced by two orders of
magnitude. On the other hand, the rate of transamination of
d-alanine (200 mm) was reduced by 50% for the H230Y
mutant. The pseudo first-order rate constants for scSHMT and
the H230Y mutant were 0.0028 s21 and 0.0012 s21, respec-
tively. The H230A and H230N proteins were unable to use
d-alanine or l-allothreonine as substrates, implying a role for a
well hydrogen-bonded H230 residue in the catalytic cycle of
SHMT.
The observation that the proton abstraction step of catalysis
and the side reactions were significantly affected by the muta-
tion of H230 prompted an examination of the reactivity of PLP
at the active site using well characterized inhibitors of SHMT
such as MA [26] and thiosemicarbazide (TSC) [27]. The
interaction of MA with scSHMT and H230Y was monitored
spectrally. The pseudo first-order rate constants for the reaction
of MA (20 mm) with scSHMT and the H230Y mutant were
0.052 min21 and 0.026 min21, respectively. Similar reduction
in the rate of the reaction was observed with aminooxyacetic
acid (data not shown) suggesting that there was an alteration in
the reactivity of the PLP-Schiff's base in H230Y.
These findings were further corroborated when the inter-
action of the proteins with TSC was examined. It was shown
earlier that TSC is a slow but tight binding inhibitor of sheep
liver SHMT [27]. An early intermediate generated upon the
interaction of TSC with sheep liver SHMT had a spectral
absorbance at 464 nm and 440 nm and the concentration of this
intermediate reached a maximal value after < 15 min of the
reaction [27]. Thereafter, the intermediate decomposed slowly
to yield the thiosemicarbazone. It was established that this
intermediate was present at the active site and the proton
abstraction at the C2 position was an important step in its
formation [27]. Upon reaction with TSC, scSHMT showed a
profile (Fig. 2B) similar to that observed earlier for the native
sheep liver SHMT [27]. Compared to scSHMT, the rates of
formation of the TSC±quinonoid intermediate and its decom-
position were rapid in the case of the H230Y mutant (Fig. 2A).
It was not possible to determine the rate constants for these
reactions, with accuracy, using conventional spectroscopic
methods. There was no change in the absorbance at 464 nm
for scSHMT, upto 10 min of the reaction; however, after 5 min,
the concentration of the intermediate had decreased substan-
tially (80%) in case of the H230Y mutant. These observations
led to the conclusion that there is probably a change in the
orientation of the PLP ring upon mutation of H230 to tyrosine
that leads to an alteration in the reaction of the enzyme with
different ligands, analogous to the situation for AATase.
An alteration in the Tm values of the protein in the presence
of serine has been correlated to the conversion of the enzyme
from an `open' to a `closed' conformation [28]. There was no
change in the Tm values of the mutant enzymes upon addition
of serine (54 ^ 2 8C), unlike the wild-type enzyme, for which
the addition of 100 mm l-serine to the holoenzyme enhanced
it's Tm value from 54 8C to 63 8C. These results indicate that
the mutant enzymes, although capable of binding the substrates
(Table 1), are unable to bring about the required conformational
change, suggesting that they may be present in a partially
closed conformation. The crystal structure of the Y225R mutant
Fig. 2. Interaction of scSHMT and the H230Y mutant with TSC.
Absorbance spectrum of the H230Y mutant (A) and scSHMT (B) (5 mm)
upon addition of TSC (2 mm) was recorded at 30 s intervals for 10 min at
37 8C. Representative spectra recorded at time intervals indicated are shown
in the figure.
Fig. 3. Size-exclusion chromatography profiles of scSHMT and H230
mutants. The proteins (0.125 mg´mL21) were analyzed on a calibrated
Superose 12 HR 10/30 column attached to a Pharmacia FPLC system. The
inset shows the gel filtration profile of apo scSHMT (Ð) prepared by
incubating the enzyme with 10 mm l-cysteine followed by dialysis. The
apoenzyme was reconstituted with 50 mm PLP at room temperature for
5 min (---). `T' represents the tetrameric form of scSHMT and the H230A,
H230N and H230Y mutants, and `D' represents the dimeric form of the
H230F and H230R mutant proteins. The standard molecular weight markers
used for calibration were: apoferritin (440 000), b-amylase (200 000), yeast
alcohol dehydrogenase (150 000), bovine serum albumin (66 000) and
carbonic anhydrase (29 000). The column was equilibrated with buffer A
containing 0.1 M KCl at a flow rate of 0.3 mL´min21. The eluent was
monitored at 280 nm.
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of AATase also showed the enzyme to be present in a partially
closed conformation [10].
Oligomeric status of the mutant proteins
It was shown earlier that mutation of residues involved in PLP
interaction lead to the dissociation of the tetrameric structure of
scSHMT [29]. The observation that the H230F and H230R
mutants did not have bound PLP whereas the H230A, H230N
and H230Y mutants contained stoichiometric amounts of
PLP (Fig. 1) necessitated an examination of the oligomeric
structure of the mutant proteins. The oligomeric status of the
freshly purified mutant enzymes was determined on a cali-
brated Superose 12 HR 10/30 analytical gel filtration column.
scSHMT and the H230A, H230N and H230Y mutants eluted
as a single symmetrical peak corresponding to a Mr of
< 210 kDa, suggesting that these proteins were tetramers
(Fig. 3). This was confirmed by estimating the amount of PLP
per subunit of the enzyme. The H230F and H230R mutant
proteins, however, eluted as symmetrical peaks with a Mr
corresponding to the dimeric form (< 110 kDa) of the enzyme.
Removal of the bound cofactor from the H230A, H230N and
H230Y mutant proteins by reaction with l-cysteine gave the
corresponding apoenzymes, which eluted as dimers, unlike the
apoenzyme for scSHMT, which was predominantly a tetramer
(Fig. 3, inset, solid trace). The mutant apoenzymes could not be
reconstituted to tetramers upon exogenous addition of PLP
(50±500 mm) whereas apo scSHMT was converted to a
tetramer that was fully active (Fig. 3, inset, dashed trace).
Enzymes are known to exert their functions not only through
the chemical properties of the amino acid sidechains present at
the active site but also through residues proximal to it. Charge
distribution throughout the active site also facilitates catalysis
by electrostatically guiding the substrate molecule into the
active site. This theme has been observed recurrently not only
in PLP-dependent enzymes [2,7±9,10] but also in other enzyme
systems like pyruvate decarboxylase [30]. In the case of
hcSHMT, it has been reported that H151 stabilizes, via hydro-
gen bonding, the negative charge on D228, which is crucial for
determining the basicity of the N1 of PLP [2]. The interaction
of PLP with the active site residues of scSHMT is depicted in
Fig. 4, based on the available crystal structure coordinates
(PDB accession number 1BJ4) of hcSHMT [2]. The X-ray
structure of hcSHMT [2] revealed the presence of a large
network of hydrogen bonding interactions at the active site
(Table 3). H231 (H230 in scSHMT) is within hydrogen
bonding distance of four residues within the same subunit,
namely, O3 0 of PLP (0.309 nm), the NH group of the internal
aldimine of K257 (0.256 nm), S203 (0.344 nm) and H357
(0.363 nm). R402, the residue binding the carboxyl group of
serine, lies 0.32 nm away from H231. The active site milieu is
highly polar as it is surrounded by charged residues such as
arginine, aspartic acid, histidine, etc. (Fig. 4). It is obvious that
H230 of scSHMT, which is equivalent to H231 of hcSHMT,
along with the pyridine ring of PLP, D227 and H150, forms a
charge relay system for effective proton abstraction from the
external aldimine. The mutation of H230 to alanine, phenyl-
alanine, asparagine, arginine or tyrosine disturbs the charge
relay by affecting the hydrogen-bond interaction with O3 0 of
PLP and altering the orientation of the PLP ring, thus affecting
catalysis to various extents.
An examination of the X-ray structure of hcSHMT revealed
that mutation of H230 of scSHMT to arginine would lead to a
strong repulsion between the newly introduced positive charge
of arginine and the R402 present nearby at the active site. This
would probably result in the disruption of the tetrameric
structure. Biochemical studies reported in this paper are in
conformity with this explanation (Fig. 3).
The introduction of a large hydrophobic residue like phenyl-
alanine in the highly polar active site pocket would affect the
overall environment leading to the dissociation of the tetramer,
explaining the dimeric nature of the H230F mutant. In both
these mutants, i.e. H230F and H230R, loss of tetrameric
structure leads to loss of catalytic activity and PLP binding.
Replacement of the H230 with asparagine, which is struc-
turally similar to histidine, does not interfere with the active site
interactions, although the hydrogen bond between O3 0 of PLP
and amide nitrogen of H230N is probably weakened. This, in
turn, could seriously affect the electron withdrawing ability of
the pyridinium nitrogen, thus leading to loss of catalytic
activity. In the case of the H230A mutant, as alanine is a small
residue it does not sterically interfere with the residues at the
active site. Both H230A and H230N mutants retain the oligo-
meric structure; however, H230A would be unable to form a
hydrogen bond with O3 0 of PLP, thus affecting the charge relay
system, leading to a drastic reduction in the catalytic efficiency.
The H231 in hcSHMT (PDB code 1BJ4) was mutated to
tyrosine using the program o [31] and the resulting contacts
were measured. Replacement of H230 with tyrosine establishes
a hydrogen-bonding interaction between the O3 0 of PLP and the
OH group of tyrosine. This hydrogen bond is stronger than that
Fig. 4. Hypothetical charge relay system operating at the active site of
scSHMT formulated on the basis of the X-ray structure of hcSHMT
(PDB accession number 1BJ4). H230 corresponds to H231 of hcSHMT.
The graphics visualization program o was used for measuring the distances
[31].
Table 3. Length of potential hydrogen bonds between cofactor and
active site residues in hcSHMT (PDB accession number 1BJ4).
Protein group(s) Hydrogen bond length (nm)
PLP O3 0±K257 NZ 0.256
PLP O3 0±H231 Nd1 0.309
PLP O3 0±S203 Og 0.381
H231 N:2±S203 O 0.344
H231 Nd1±S203 O 0.344
H231 O±H357 N:2 0.363
H231 N:2±R402 NH1 0.327
D228 Od2±H151 N:2 0.265
D228 Od2±PLP N1 0.276
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with H230 as the distance between the two atoms decreases to
0.246 nm compared to 0.309 nm in the wild-type protein.
However, this interaction decreases the bond distance between
O3 0 of PLP and the OH group of S203 (0.137 nm compared to
0.381 nm in wild-type protein). In order to accommodate a
tyrosine residue more effectively in the active site, S203 had to
be rotated away from the O3 0 of PLP, disrupting the hydrogen
bonding originally present in the wild-type enzyme. An import-
ant consequence of such a change could be that the basicity of
N1 of PLP would be altered, thereby partially disrupting the
charge relay system and affecting catalysis. Confirmation of
these explanations, however, has to await the elucidation of the
three-dimensional structure of the H230 mutants of SHMT.
The results presented above demonstrate that H230, which is
hydrogen bonded to O3 0 of PLP and is part of a charge relay
system, facilitates effective proton abstraction, an important
event in the catalytic cycle of SHMT.
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